Justin Wilson

USPTO Granted Patents = 9 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

University of California

patents

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12258339 - Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer (2025-03-25),

2. 12103922 - Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer (2024-10-01),

3. 11884685 - Rhenium complexes and methods of use for treating cancer (2024-01-30),

4. 11708283 - Metal-chelating compositions and their use in methods of removing or inhibiting barium scale (2023-07-25),

5. 11554182 - Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer (2023-01-17),

6. 11279698 - Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer (2022-03-22),

7. 11154569 - Ruthenium μ-nitrido complexes and their use as calcium uptake inhibitors (2021-10-26),

8. 10973849 - Rhenium complexes and methods of use for treating cancer (2021-04-13),

9. 10392412 - Platinum anticancer agents (2019-08-27),

Title: Innovations of Justin Wilson in Targeted Radiotherapy

Introduction

Justin Wilson is an accomplished inventor based in Ithaca, NY (US), known for his significant contributions to the field of targeted radiotherapy. With a total of 9 patents to his name, Wilson has made remarkable advancements in the use of macrocyclic complexes of alpha-emitting radionuclides for cancer treatment.

Latest Patents

His latest patents focus on the development of compounds and compositions that are useful in targeted radiotherapy of cancer. These innovations specifically target mammalian tissue that overexpresses prostate-specific membrane antigen (PSMA). The technology provides a promising approach to enhance the effectiveness of cancer treatments.

Career Highlights

Throughout his career, Justin Wilson has worked with prestigious institutions such as Cornell University and Temple University. His research and inventions have played a crucial role in advancing medical technologies aimed at improving patient outcomes in cancer therapy.

Collaborations

Wilson has collaborated with notable colleagues, including Nikki Thiele and John W Babich, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Justin Wilson's work in the field of targeted radiotherapy exemplifies the impact of innovative thinking in medicine. His patents and collaborations continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.